Patient State
Model the patient, not the average
How subtype, stage, biomarkers, risk, and trajectory become the starting context for every therapeutic hypothesis.
Explore Topic
AI Robotix Biomedical Initiative
ALZHEIMERINTELLIGENCEPLATFORM
An AI-native biomedical initiative integrating multi-omic, clinical, and computational data to model Alzheimer's disease progression, identify biomarkers, discover therapeutic targets, and accelerate translational research through scalable scientific infrastructure.
Integrate
Fuse multi-omic profiles, clinical records, literature, and computational features into one disease intelligence layer.
Model
Map Alzheimer's progression across stages, subtypes, biomarkers, and intervention scenarios with AI-native systems biology.
Translate
Prioritize biomarkers and therapeutic targets, then move the strongest evidence into validation plans for collaborators.
Platform Core
AI-NATIVEBIOMEDICALINTELLIGENCE
The platform converts heterogeneous biomedical evidence into computable Alzheimer's disease models, then uses AI and systems biology to surface biomarkers, targets, and translational next steps.
Data Foundation
Multi-omic and clinical integration
Unifies molecular, clinical, literature, imaging, and computational signals into a shared Alzheimer intelligence layer.
Disease Modeling
Progression intelligence
Models how disease state, subtype, trajectory, and risk may evolve across preclinical and clinical stages.
Discovery Engine
Biomarkers and therapeutic targets
Ranks candidate biomarkers, mechanisms, and targets by evidence strength, biological plausibility, and translational potential.
Research Infrastructure
Validation-ready translation
Packages platform findings into assays, dataset checks, collaborator workflows, and go/no-go research plans.
Progression models
Biomarker signatures
Target hypotheses
Translational research paths
Our Approach
FROM PATIENT STATETO TESTABLE BIOLOGY
The project uses a therapeutic hypothesis platform to connect patient subtypes, disease stage, causal mechanisms, evidence, and intervention strategy. Each technical output becomes a testable hypothesis with expected biomarker movement, safety risks, trial implications, and a validation path.
- The platform turns patient-state vectors into structured therapeutic hypotheses
- The platform favors subtype over averages: biology depends on stage, trajectory, context, and risk
- Evidence over assumption: every platform-ranked path is scored, supported, and testable
StatePlatform patient-state vectors, subtype, and stage
HypothesisStructured platform records for intervention rationale
EvidencePlatform scores for support, contradiction, and safety
SimulationPlatform models for biomarkers, endpoints, and trial risk
ValidationPlatform-generated assay plans and go/no-go criteria
The Team
BUILT ACROSS DISCIPLINES
The Alzheimer's Project is built by a multidisciplinary team where computation, biology, neuroscience, and clinical research move as one connected system.
AI researchers and ML engineers build the therapeutic hypothesis platform. Neuroscientists, molecular biologists, data scientists, physicians, and INTEC collaborators ground every platform-ranked hypothesis in real brain biology, clinical relevance, and validation discipline.
Latest Insights
INSIGHTS
Field notes from The Alzheimer's Project: patient-state modeling, the therapeutic hypothesis object, evidence ranking, and the validation loop that turns predictions into evidence.
Hypothesis Object
Turn mechanisms into testable records
How a mechanism, intervention direction, expected biomarker movement, safety risk, and assay plan become one structured record.
Explore Topic
Evidence Ranking
Choose what deserves testing
How support, contradiction, human relevance, subtype clarity, safety, and feasibility shape the next experimental priority.
Explore Topic
Validation Loop
Design the experiment that can disprove it
How tissue, perturbation, biomarkers, and clinical context define go/no-go criteria before an idea becomes a development path.
Explore Topic